Erasca, Inc. (ERAS)
NASDAQ: ERAS · Real-Time Price · USD
19.02
0.00 (0.00%)
Jul 17, 2026, 11:47 AM EDT - Market open
Erasca Market Cap
Erasca has a market cap or net worth of $6.51 billion as of July 17, 2026. Its market cap has increased by 1,496.51% in one year.
Market Cap
6.51B
Enterprise Value
6.15B
1-Year Change
1,496.51%
Ranking
Category
Stock Price
$19.02
ChartMarket Cap Chart
Since the IPO on July 16, 2021, Erasca's market cap has increased from $1.86B to $6.51B, an increase of 250.47%. That is a compound annual growth rate of 28.47%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2026 | 6.51B | 517.08% |
| Dec 31, 2025 | 1.06B | 48.72% |
| Dec 31, 2024 | 709.65M | 121.27% |
| Dec 29, 2023 | 320.72M | -50.41% |
| Dec 30, 2022 | 646.73M | -65.76% |
| Dec 31, 2021 | 1.89B | 1.66% |
| Jul 16, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rhythm Pharmaceuticals | 7.33B |
| Mirum Pharmaceuticals | 7.23B |
| Xenon Pharmaceuticals | 6.64B |
| Cogent Biosciences | 6.63B |
| PTC Therapeutics | 6.50B |
| CG Oncology | 6.37B |
| Scholar Rock Holding | 6.33B |
| Ligand Pharmaceuticals | 5.92B |